Patent ID: 6849654

Claim:
A pharmaceutical composition comprising an MT-3 agonist of the following formula I: wherein R is —S(O) 2 R 1 or S(O)R 1 , R 1 is optionally substituted alkyl; optionally substituted alkoxy; optionally substituted aminoalkyl; optionally substituted carbocyclic aryl; an optionally substituted alkylaryl; R 2 is hydrogen, halogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted alkylthio, optionally substituted alkylsulfonyl, optionally substituted aminoalkyl; and pharmaceutically acceptable salts thereof, R 3 is hydrogen, halogen, optionally substituted alkyl, optionally substituted alkenyl, optionally substituted alkynyl, optionally substituted alkoxy, optionally substituted alkylthio, optionally substituted alkylsulfonyl, optionally substituted aminoalkyl, optionally substituted carbocyclic aryl, or optionally substituted aralkyl; and pharmaceutically acceptable salts thereof, wherein the optional substituents, which may be at one or more available positions, are selected from the group consisting of halogen, cyano, hydroxyl, nitro, azido, C 1-6 alkanoyl, carboxamido, alkyl, alkenyl, alkynyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl and aminoalkyl with the proviso that when R 1 is methyl, R 2 cannot be iodine or bromine and when R 1 is methyl, R 2 and R 3 cannot both be hydrogen and a pharmaceutically acceptable carrier.